Seeking AlphaCodex · 实盘不做把握 5/10不做原因:无增量信息
北京时间·🕒 发布 19:07:58(美东 07:07)·⟳ 抓取 19:08:05 +7s·⚡ 决策 08-24 19:11:15 +3m10s·63.8 天前
ARK Invest上周加仓SpaceX、Cerebras、英伟达和博通,同时减持Roblox、Palantir和AMD
本事件只是ARK Invest上一交易周调仓的媒体汇总,对被买卖公司的经营、财务、订单、指引或监管状态没有新增事实;单一基金买卖金额相对主要标的市值和流动性不足以形成方向一致、可执行的短线edge。
📄 原文Seeking Alpha↗ 原文
SpaceX continues to be Cathie's biggest bet; trims RBLX, PLTR, and AMD
Cathie Wood’s Ark Invest increased exposure to AI infrastructure, biotechnology, fintech, and space-related technologie…
不做 NVIDIA(NVDA.US)
ARK约2280万美元买入不是NVIDIA基本面新增,且金额相对市值和流动性太小,无可交易edge。
不做 CSOP NVIDIA Daily Max 2x Leveraged Product(07788.HK)
底层NVIDIA没有可交易利多,2倍做多产品不应放大无edge事件。
不做 CSOP NVIDIA Daily Max 2x Leveraged Product(09788.HK)
底层NVIDIA没有可交易利多,美元柜台2倍做多产品不适合参与。
不做 CSOP NVIDIA Daily Max -2x Inverse Product(07388.HK)
事件不是NVIDIA利空,反向产品缺少做空依据。
不做 CSOP NVIDIA Daily Max -2x Inverse Product(09388.HK)
事件不是NVIDIA利空,美元柜台反向产品缺少做空依据。
不做 Broadcom(AVGO.US)
ARK加仓属于外部基金流向,未改变Broadcom收入、订单或指引预期。
另有 3 腿,见展开详情。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
其余 3 腿
不做 Roblox(RBLX.US)
ARK减持不构成Roblox直接、实质、公司级新增利空,不能作为做空催化。
不做 Palantir Technologies(PLTR.US)
ARK减持金额不足以构成Palantir强空事件,缺少发行人负面事实。
不做 Advanced Micro Devices(AMD.US)
ARK卖出只是基金仓位调整,不是AMD需求、客户或业绩预期下修。
研究档案
结论摘要
Seeking Alpha报道ARK上周买入SpaceX、Cerebras、NVIDIA、Broadcom等并卖出Roblox、Palantir、AMD等,但这是资金流信息而非发行人一手催化。直接载体扫描覆盖了NVIDIA正股及香港2倍/反向产品,以及AVGO、RBLX、PLTR、AMD主上市候选;由于底层事件没有公司级增量,杠杆或反向载体也没有正期望。
🔎 新鲜度:最早出现 2026-08-24 · 扩散 medium · price-in 风险 high ↗
消息传播链
- Seeking Alpha在美股盘前汇总ARK 8月17日至21日交易周的主要买卖,属于调仓信息扩散而非发行人一手公告。
主要风险
- 若市场短线跟随Cathie Wood调仓叙事,个别小盘或低流动性持仓可能出现情绪波动,但本事件没有足够发行人级因果证据。
- NVIDIA本周将公布财报,真正价格驱动应来自财报和指引,而不是ARK盘前调仓汇总。
反向证据
- 做多前查反向 · 来源 web · 日期 2026-08-24 · 影响 weakens
正文未显示NVIDIA或Broadcom新增订单、指引上调、客户采购承诺或发行人一手经营增量。
检索:ARK Invest weekly trades Nvidia Broadcom August 2026 issuer fundamental catalyst 原文 ↗ - 做空前查反向 · 来源 web · 日期 2026-08-24 · 影响 weakens
正文未显示Roblox、Palantir或AMD出现业绩下修、客户流失、监管处罚等明确强空催化。
检索:ARK Invest trims Roblox Palantir AMD August 2026 fundamental negative news 原文 ↗
先例如何影响了这次决策
对本次决策的影响:先例不足且机制弱,最终确认不做任何方向性订单。
方向:没有采用外部价格先例支撑交易;基金周度调仓汇总与发行人基本面事件相似度不足。
涨幅量级:缺少高相似、同市场、同机制且能锚定到被交易股票的先例,无法校准tp/sl。
形态:这类外部基金买卖更接近情绪和流向信息,不能替代订单、业绩或指引等公司级催化。
原文全文
展开原文 · 2,715 字
Cathie Wood’s Ark Invest increased exposure to AI infrastructure, biotechnology, fintech, and space-related technologies during the August 17-21 trading week while making significant reductions in software and technology holdings.
SpaceX (SPCX) was Ark’s biggest purchase of the week by estimated value, with 205,031 shares bought for ~$28M. The latest purchase extends Wood’s continued accumulation of the satellite company, with Ark repeatedly adding to the position week after week, underscoring her strong conviction in the company.
Cerebras Systems (CBRS) was the second-largest addition at about $25M, following its collaboration with London-based AI and compute software company Callosum to bring next-generation AI inference to market.
Nvidia (NVDA) was also a significant purchase, with 101,356 shares bought for an estimated $22.8M. Ark added to its Nvidia (NVDA) position just ahead of the chipmaker’s quarterly results, scheduled for Wednesday, as investors await another key update on AI infrastructure demand and the company’s growth outlook.
Broadcom (AVGO) saw 55,548 shares added for about $20M, while BWX Technologies (BWXT) received 117,071 shares worth ~$18.3M, increasing Ark’s exposure to advanced nuclear and defense-related technologies.
The portfolio manager also bought 1M shares of ARK Active Autocallable Income ETF (ARKY) on August 19, adding to its exposure to the ARK-branded income strategy. Ark also made a separate $20M addition to Cloudflare (NET), making it one of the week's notable purchases.
In healthcare and biotechnology, Ark added to Perceptive Capital Solutions (FRNM), Cerus (CERS), Ionis Pharmaceuticals (IONS), Intellia Therapeutics (NTLA), Tempus AI (TEM) and Scribe Therapeutics (SCTX). Other purchases included Nu Holdings (NU), Futu Holdings (FUTU), Block (XYZ) and Docusign (DOCU).
On the selling side, Roblox (RBLX) was the firm’s largest reduction, with 1.284M shares sold for an estimated $49M.
Palantir Technologies (PLTR) was the next-largest reduction, with 196,189 shares sold for about $34.5M. Advanced Micro Devices (AMD) followed, with 64,239 shares sold for ~$31M.
Shopify (SHOP) was cut by 195,320 shares, representing about $28.9M in estimated sales. Ark also reduced 10x Genomics (TXG) by 410,643 shares, worth ~$25M based on the average share price during the last week.
Twist Bioscience (TWST) was also reduced by 138,742 shares, representing a ~$18M sale, making it one of Ark’s larger reductions during the week.
Other notable reductions included Illumina (ILMN), with an estimated $9.8M worth of shares sold, followed by Natera (NTRA) at $6.5M and Deere (DE) at $3.9M. Ark also reduced positions in AtaiBeckley (ATAI) and Brera Holdings (SLMT).
SpaceX (SPCX) was Ark’s biggest purchase of the week by estimated value, with 205,031 shares bought for ~$28M. The latest purchase extends Wood’s continued accumulation of the satellite company, with Ark repeatedly adding to the position week after week, underscoring her strong conviction in the company.
Cerebras Systems (CBRS) was the second-largest addition at about $25M, following its collaboration with London-based AI and compute software company Callosum to bring next-generation AI inference to market.
Nvidia (NVDA) was also a significant purchase, with 101,356 shares bought for an estimated $22.8M. Ark added to its Nvidia (NVDA) position just ahead of the chipmaker’s quarterly results, scheduled for Wednesday, as investors await another key update on AI infrastructure demand and the company’s growth outlook.
Broadcom (AVGO) saw 55,548 shares added for about $20M, while BWX Technologies (BWXT) received 117,071 shares worth ~$18.3M, increasing Ark’s exposure to advanced nuclear and defense-related technologies.
The portfolio manager also bought 1M shares of ARK Active Autocallable Income ETF (ARKY) on August 19, adding to its exposure to the ARK-branded income strategy. Ark also made a separate $20M addition to Cloudflare (NET), making it one of the week's notable purchases.
In healthcare and biotechnology, Ark added to Perceptive Capital Solutions (FRNM), Cerus (CERS), Ionis Pharmaceuticals (IONS), Intellia Therapeutics (NTLA), Tempus AI (TEM) and Scribe Therapeutics (SCTX). Other purchases included Nu Holdings (NU), Futu Holdings (FUTU), Block (XYZ) and Docusign (DOCU).
On the selling side, Roblox (RBLX) was the firm’s largest reduction, with 1.284M shares sold for an estimated $49M.
Palantir Technologies (PLTR) was the next-largest reduction, with 196,189 shares sold for about $34.5M. Advanced Micro Devices (AMD) followed, with 64,239 shares sold for ~$31M.
Shopify (SHOP) was cut by 195,320 shares, representing about $28.9M in estimated sales. Ark also reduced 10x Genomics (TXG) by 410,643 shares, worth ~$25M based on the average share price during the last week.
Twist Bioscience (TWST) was also reduced by 138,742 shares, representing a ~$18M sale, making it one of Ark’s larger reductions during the week.
Other notable reductions included Illumina (ILMN), with an estimated $9.8M worth of shares sold, followed by Natera (NTRA) at $6.5M and Deere (DE) at $3.9M. Ark also reduced positions in AtaiBeckley (ATAI) and Brera Holdings (SLMT).
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。